Fisher Peter P - OmicsDI

Show results for

Proteomics (125)
Unknown (86)
Transcriptomics (64)
Genomics (42)
Metabolomics (21)

Organisms

Schizosaccharomyces pombe (120)
Oryza sativa Indica Group (120)
Sinorhizobium meliloti BL225C (120)
Sus scrofa domesticus (120)
Saccharomyces cerevisiae (120)
Staphylococcus aureus (120)
Rattus norvegicus (120)
Escherichia coli (120)
Entamoeba histolytica (120)
Physcomitrium patens (120)
Methylohalobius crimeensis 10Ki (120)
Homo sapiens (120)
Homo sapiens (65)
Mus musculus (21)
Rattus norvegicus (5)
Caenorhabditis elegans (3)
Triticum aestivum (2)
Ictalurus punctatus x Ictalurus furcatus (1)
Salmo trutta (1)
Vibrio campbellii (1)
human gut metagenome (1)
Populus tremuloides (1)
Brassica napus (1)
Oryctolagus cuniculus (1)
Oncorhynchus mykiss (1)
Bos taurus (1)
Saccharomyces cerevisiae (1)
Drosophila melanogaster (1)
Danio rerio (1)
Onchocerca volvulus (1)

Organisms

Mus musculus (1)

Repository

pride (120)
biostudies-arrayexpress (71)
EGA (36)
MetaboLights (21)
MassIVE (2)
iProX (1)
ENA (1)

Tissue

Cell culture (21)
Brain (8)
Epithelial cell (7)
Blood serum (6)
Leaf (6)
Plant cell (5)
Permanent cell line cell (5)
Prostate adenocarcinoma cell line (3)
Epithelial cell of prostate (3)
Endothelial cell (3)
Blood plasma (3)
Embryo (3)
Blood cell (3)
Electrically active cell (2)
Seed (2)
Macrophage (2)
Stem cell (2)
Testis (2)
Lung (2)
Kidney (2)
Liver (2)
Colon (2)
Blood (2)
Palatine tonsil (1)
Parotid gland (1)
Nasal polyp (1)
Skeletal muscle tissue (1)
Cartilage tissue (1)
Proliferating skeletal muscle satellite cell (1)
Myoblast maturation (1)

Disease

Disease free (4)
Prostate carcinoma (3)
Malignant neoplasm of ovary (2)
Leukemia (1)
Fascioliasis (1)
Polyneuropathy (1)
Babesiosis (1)
Major depressive disorder (1)
Uterine inflammatory disease (1)
Coronavirus infectious disease (1)
Depression (1)
Brain ischemia (1)
Leukodystrophy (1)
Plasmodium falciparum malaria (1)
Mixed disorder as reaction to stress (1)
Renal clear cell carcinoma (1)
Lung cancer (1)
Visceral leishmaniasis (1)
Cardiovascular system disease (1)
Colorectal cancer (1)
Leishmaniasis (1)
Alzheimer's disease (1)
Kidney cancer (1)
Breast cancer (1)
Wounds and Injuries (1)
Colon cancer (1)
Acute leukemia (1)

Technology Type

Mass Spectrometry (120)
Shotgun proteomics (62)
Bottom-up proteomics (24)
Mass spectrometry (17)
Affinity purification coupled with mass spectrometry proteomics (16)
Data-dependent acquisition (14)
Gel-based experiment (13)
Illumina 15K (8)
SWATH MS (7)
Mass spectrometry assay (4)
All-ion fragmentation (3)
SRM/MRM (3)
Data-independent acquisition (2)
Top-down proteomics (2)
AB SOLiD 4 System, Illumina HiSeq 2500, Illumina HiSeq 2000, AB SOLiD System 3.0 (1)
RNA mass spectrometry (1)
Affinity proteomics (1)
Chemical cross-linking coupled with mass spectrometry proteomics (1)

Instrument Platform

Illumina NovaSeq 6000 (7)
Illumina HiSeq 4000 (4)
Liquid Chromatography MS - alternating - reverse phase (4)
NextSeq 500 (3)
Liquid Chromatography MS - positive - hilic (3)
Liquid Chromatography MS - negative - reverse phase (3)
Qubit 4.0 Fluorometer/ Agilen 5300 Fragment Analyzer (2)
Illumina BeadArray reader (2)
MS Imaging - (2)
Liquid Chromatography MS - alternating - hilic (2)
Liquid Chromatography MS - negative - hilic (2)
ArrayWoRx Multi-Format Reader [Applied Precision] (1)
FS450 (1)
GCS3000 (1)
Illumina Genome Analyzer II (1)
Illumina HiSeq X (1)
Illumina HiSeq 1500 (1)
Illumina HiSeq 2500 (1)
Illumina HiSeq 2000 (1)
SolariX (1)
Orbitrap Exploris 480 (1)
LTQ Orbitrap XL ETD (1)
Orbitrap Fusion (Thermo Fisher Scientific)_negative (1)
Orbitrap Fusion (Thermo Fisher Scientific) (1)
Direct infusion MS - (1)
Exactive (1)
Autoflex speed smartbeam (1)
Gas Chromatography MS - (1)
Liquid Chromatography MS - Alternating (LC-MS (Alternating)) (1)
Gas Chromatography MS - positive (1)

Publication Date

2026 (26)
2021 (24)
2020 (22)
2024 (21)
2014 (20)
2022 (18)
2023 (16)
2012 (12)
2025 (11)
2018 (10)
2019 (9)
2013 (7)
2017 (5)
2016 (5)
2011 (3)
2010 (3)
2015 (2)
2006 (1)

CHEBI ID

CHEBI:18237 (5)
CHEBI:17822 (4)
CHEBI:16811 (4)
CHEBI:28300 (4)
CHEBI:24898 (4)
CHEBI:15756 (4)
CHEBI:16708 (3)
CHEBI:15428 (3)
CHEBI:15741 (3)
CHEBI:6650 (3)
CHEBI:28044 (3)
CHEBI:73024 (3)
CHEBI:29016 (3)
CHEBI:67066 (2)
CHEBI:66860 (2)
CHEBI:136345 (2)
CHEBI:78647 (2)
CHEBI:42504 (2)
CHEBI:67064 (2)
CHEBI:67065 (2)
CHEBI:67076 (2)
CHEBI:64591 (2)
CHEBI:64592 (2)
CHEBI:85742 (2)
CHEBI:84659 (2)
CHEBI:85743 (2)
CHEBI:84660 (2)
CHEBI:84661 (2)
CHEBI:85733 (2)
CHEBI:84662 (2)

Metabolite Name

Methionine (4)
Adenine (4)
D-Glucose (3)
Glutamate (3)
Pyroglutamic acid (3)
Tryptamine (3)
L-Histidine (3)
Choline (3)
Taurine (3)
Glutamine (3)
L-Leucine (3)
L-Phenylalanine (3)
PE O-38:4 (2)
PE O-36:5 (2)
PE O-36:2 (2)
PE O-36:3 (2)
PE O-38:5 (2)
PS 42:6 (2)
PS 36:4 (2)
PE O-40:6 (2)
PE O-38:6 (2)
PC O-38:2 (2)
PC O-36:1 (2)
PC O-36:4 (2)
PS 38:6 (2)
PS 38:2 (2)
PC O-36:2 (2)
PC O-34:2 (2)
PC O-34:1 (2)
PC 38:1 (2)

First Public Date

2023 (1)

Modification

N6 (1)

Study type

Transcription profiling by array (43)
RNA-seq of coding RNA (17)
ChIP-seq (4)
Cell line - High-throughput sequencing (2)
Proteomic profiling by array (2)
Transcription profiling by SAGE (1)
RNA-seq of non coding RNA from single cells (1)
DNA-seq (1)

Release Date

2014 (21)
2012 (15)
2024 (14)
2022 (13)
2021 (13)
2020 (12)
2023 (11)
2026 (8)
2025 (8)
2013 (7)
2017 (6)
2016 (6)
2019 (5)
2010 (5)
2011 (4)
2018 (3)
2015 (2)
2009 (2)
2006 (1)
2008 (1)

Lab affiliation

School of Biochemistry, Faculty of Life Sciences, University of Bristol,UK (6)
Department of Glycobiology, Institute of Chemistry, Slovak Academy of Sciences (5)
Institute of Plant Genetics, Leibniz Universitaet Hannover, Germany (4)
CRUK - Beatson Institute for Cancer Research - Switchback Rd, Bearsden, Glasgow G61 1BD - United Kingdom (3)
VetMedZg Laboratory,Faculty of Veterinary Medicine, University of Zagreb, Zagreb, Croatia Institute of Biodiversity, Animal Health & Comparative Medicine, College of Medicine, Veterinary Medicine and Life Sciences, University of Glasgow, Glasgow, UK (2)
Robert Koch-Institute, Centre for Biological Threats and Special Pathogens, Proteomics and Spectroscopy (ZBS6), Berlin, Germany (2)
The Hospital For Sick Children, Program in Molecular Structure and Function, Princess Margaret Cancer Centre, and Department of Molecular Genetics, University of Toronto. Peter Gilgan Centre for Research and Learning, 686 Bay Street, Toronto M5G 0A4, Canada (2)
Division of Cancer Epigenomics, German Cancer Research Center (DKFZ), INF280, 69120 Heidelberg, Germany (2)
Department of Microbiology and Immunology, University of Melbourne, Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia (2)
The Sir Peter MacCallum Department of Oncology, The University of Melbourne, Victoria, Australia (2)
Institute of Chemistry, Slovak Academy of Sciences (2)
VetMedZg Laboratory,Faculty of Veterinary Medicine, University of Zagreb, Zagreb, Croatia Institute of Biodiversity, Animal Health & Comparative Medicine, College of Medicine, Veterinary Medicine and Life Sciences, University of Glasgow, Glasgow, UK (2)
Department of Microbiology and Immunology, University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne 3000, Australia (2)
The Department of Microbiology and Immunology at the Peter Doherty Institute, The University of Melbourne, Victoria, Australia (1)
Peter Lasch, Centre for Biological Threats and Special Pathogens, Proteomics and Spectroscopy (ZBS6), Berlin, Germany (1)
University of Southern Denmark, Department of Biochemistry and Molecular Biology, Protein Research (1)
1Department of Chemistry & Biochemistry, University of Maryland, College Park, MD 20742 (1)
Laboratory of Experimental Hematology, Vaccine and Infectious Disease Institute (Vaxinfectio), University of Antwerp, 2610 Wilrijk, Belgium (1)
University of Groningen, Department of Analytical Biochemistry, Groningen Research Institute of Pharmacy, Antonius Deusinglaan 1, 9713 AV, Groningen, The Netherlands. (1)
School of BioSciences, The University of Melbourne, Victoria, Australia (1)
Professor of the Department of Cell Biology and Associate Dean for Graduate Biomedical Education (1)
Peter Brodersen, Department of Biology, University of Copenhagen, Ole Maaløes Vej 5, DK-2200 Copenhagen N, Denmark (1)
Department of Molecular Mechanisms of Disease, University of Zurich, Winterthurerstrasse 190, 8057 Zurich, Switzerland (1)
Institute for Clinical Chemistry, Medical Faculty Mannheimof the University of Heidelberg (lab head) (1)
Plant & Soil Science Building 1066 Bogue St, Rm A494E East Lansing, MI 48824 Michigan State University, United states. (1)
Veterinary Parasitology Group, Institute of Biological Environmental and Rural Sciences (IBERS), Aberystwyth University, Penglais, Aberystwyth, Ceredigion, SY23 3FL (1)
University of Bristol, School of Biochemistry (1)
Turku Proteomics Facility, Turku Bioscience (1)
Laboratory of Cellular Transport Systems, Dpt. of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium (1)
Department of Pathology and Cell Biology, Columbia University Medical Center, New York, NY, USA (1)

Tags

xref:PubMed:37465665 (1)

Previous page
1 / 34
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 34
Next page

Sort by:

Relevance

Page size

Assessing discards in an illegal small-scale fishery using fisher-led reporting.

Not available

S-EPMC8958935 | biostudies-literature

Confident identification of citrullinated peptides from P gingivalis

Porphyromonas gingivalis is a key pathogen in the development of chronic periodontitis and has recently been linked to the development of rheumatoid arthritis and Alzheimer’s disease. In this project the outer membrane vesicles (OMV) from Pg have been analyzed using a two-dimensional HFBA-based sepa...

ORGANISM(S): Porphyromonas gingivalis (strain ATCC BAA-308 / W83)

2019-11-22 | PXD015701 | Pride

The identification of onchocerciasis biomarker candidates directly in human serum and urine

Onchocerca volvulus, the causative agent of onchocerciasis, infects over 20 million people and can cause severe dermatitis and ocular conditions including blindness. Current mass drug administration treatments do not kill female O. volvulus worms, and common diagnostic tests cannot reliably assess t...

ORGANISM(S): Homo Sapiens Onchocerca Volvulus

2022-11-22 | PXD033659 |

A mixed-methods pilot study of domiciliary nasal high-flow therapy for breathlessness in people with chronic obstructive pulmonary disease who do not qualify for domiciliary long-term oxygen therapy.

Not available

S-EPMC11898029 | biostudies-literature

Veterinary trypanocidal benzoxaboroles are peptidase-activated prodrugs (T. congolense assay)

Livestock diseases caused by Trypanosoma congolense, T. vivax and T. brucei, collectively known as nagana, are responsible for billions of dollars in lost food production annually. There is an urgent need for novel therapeutics. Encouragingly, promising antitrypanosomal benzoxaboroles are under v...

2020-10-22 | MTBLS1309 | MetaboLights

miRNA Expression Profiling in Ovarian Cell Lines compared to pooled commercial RNA samples

We investigated whether levels of serum microRNAs (miRNAs) could discriminate women with high-grade serous ovarian epithelial cancer (SEOC) from age matched healthy volunteers. miRNA expression profiling was performed on 4 SEOC cell lines and normal human ovarian surface epithelial cells (HOSE). miR...

ORGANISM(S): Homo sapiens

2012-02-22 | E-GEOD-35951 | biostudies-arrayexpress

Light-Driven Waste-To-Value Upcycling: Bio-Based Polyols and Polyurethanes from the Photo-Oxygenation of Cardanols.

Not available

S-EPMC8456804 | biostudies-literature

Long-term monitoring of tropical alpine habitat change, Andean anurans, and chytrid fungus in the Cordillera Vilcanota, Peru: Results from a decade of study.

Not available

S-EPMC5330894 | biostudies-literature

Cohesin is involved in transcriptional repression of invasion-related genes

The most virulent human malaria parasite, Plasmodium falciparum, has a complex life cycle between its human host and mosquito vector. Each stage is driven by a specific transcriptional program, but with a relatively high ratio of genes to specific transcription factors, it is unclear how genes are a...

ORGANISM(S): Homo sapiens (Human)

2023-10-04 | PXD035225 | Pride

Plasmodium Smc3 Cohesin

Chlorophyll biosynthesis under the control of arginine metabolism.

In natural environments, photosynthetic organisms adjust their metabolism to cope with the fluctuating availability of combined nitrogen sources, a growth-limiting factor. For acclimation, the dynamic degradation/synthesis of tetrapyrrolic pigments, as well as of the amino acid arginine, is ...

2024-03-12 | MTBLS8336 | MetaboLights

Previous page
1 / 34
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 34
Next page

Sort by:

Relevance

Page size

338 Results

Show results for

Organisms

Organisms

Repository

Tissue

Disease

Technology Type

Instrument Platform

Publication Date

CHEBI ID

Metabolite Name

First Public Date

Modification

Study type

Release Date

Lab affiliation

Tags

OmicsDI is part of the ELIXIR infrastructure

Tweets